Hannah King is an investor at BGF, the UK and Ireland’s most active growth capital firm, with over ten years of experience supporting ambitious businesses across a diverse range of sectors, including technology, manufacturing, business support services and consumer.

Specialising in scaling high-growth companies, Hannah has partnered with management teams to support succession planning, building high-performance teams, international expansion and strategic acquisitions, to unlock long-term value and achieve growth ambitions.

Beyond her investment work, Hannah is passionate about fostering inclusivity and opportunity within the entrepreneurial ecosystem. She actively mentors individuals both internally and externally, and is involved with various initiatives to support underrepresented leaders.

A qualified accountant with over 30 years of experience in industry covering sectors such as
automotive, manufacturing, print, food, medical devices, cosmetics and personal care.
As the Group MD for the Goonvean Group, a key focus and responsibility is setting Group
strategy, including an active M&A programme.

Previous employment with AutoLogic Holdings, Lex, Invensys, British Ceramic Tiles, MPG
Group, Thatchers Cider, Westfield Medical, Swallowfield plc, KDC/One.

Strong managerial background and high-calibre expertise in finance, operations and business
development. An exceptional level of diverse business experience.

I am a qualified chartered accountant (Coopers & Lybrand) and having left practice in 1990 I have built my career in the food industry.

Currently I am a Non Exec Director at AGBarr plc and non Exec Chair at Plant Ex ltd, having sat as Non Exec at Edward Billington’s ltd and Higgidy ltd.

In my Executive career I was CEO of Eldridge Pope PLC a pub company , Natures way Food td a food manufacturing company and IGD a charity that sits at the heart of the food industry working with Government.

In my earlier career I worked with in the UK and abroad in various roles with Geest (now Bakkavor) and Whitbread.

Rebecca holds chair, non-executive director and advisory roles across SMEs and large corporates within PLC, private equity, family owned and employee-owned organisations. Across the South West these include Riverford Organic Farmers, Ruroc and Gilcrest Manufacturing aswell as previously sitting on the board at Clarks. Former MD of Dyson GB&I and CEO of Pure Electric, Rebecca was voted Top 10 in the 100 Most Influential Women in Engineering 2019
Rebecca is also an active mentor and champion of inclusivity and diversity as well as an ambassador and past pupil mentor for Bristol Grammar School.

Simon enjoyed a 20+ year career in private equity, investing primarily in either technology or people based service businesses of less than £25m revenue at the time of investment. His role included building out the bandwidth and capabilities of management teams (often including CFO appointments), strategic financial analysis in particular with regard to decision-making in additional products, services and technology, improving management information and reporting, investing in systems and infrastructure and assessing and implementing acquisition strategies.

Simon is now enjoying using these skills and experiences to assist privately owned businesses to accelerate their growth. He is currently NED/ Board adviser for P1 Investment Management (providing investment management advice and platform services to IFAs), for Spherica (an IT Managed Services Provider) and for Evolution Claims Management (an insurance claims management business). He is also fractional CFO for a start-up business providing mobile veterinary services (Tony’s Mobile Vets).

Emma is an accomplished business leader and strategic advisor, specialising in life
sciences, healthcare, and med-tech sectors. With a proven track record of driving business
transformation and scaling organisations, she has held executive and non-executive roles
across industry-leading businesses.

As a Non-Executive Director at UK Bio Centre, Emma provides strategic direction on
governance, investment opportunities, and commercial performance.. Additionally, as Non-
Executive Director and Chair of the Commercial Forum at Brain in Hand, she supports the
executive team in market expansion into North America.

Previously, Emma served as CEO of Torbay Pharmaceuticals, where she transformed the
business from NHS ownership to private equity, spearheading geographic expansion into 20
countries . Under her leadership, revenue more than doubled, with operational efficiencies
delivering substantial growth.

Emma's consulting career further showcases her expertise in strategy development, market analysis, and organisational transformation, helping businesses navigate complex industry challenges. Her ability to bridge strategic vision with tactical execution has made her a sought-after advisor for growth-stage companies and market pivots.

With deep experience in governance, commercial strategy, and business transformation,
Emma continues to play a critical role in shaping the future of healthcare and life sciences
organisations.